Associations of selenium status with all-cause and cause-specific mortality: a systematic review and meta-analysis of cohort studies

source extracted confidence: high 2026-04-09
#humans #selenium #cardiovascular-diseases #neoplasms #biomarkers

Associations of selenium status with all-cause and cause-specific mortality: a systematic review and meta-analysis of cohort studies

Cui et al., 2025 | Redox Biol | Meta Analysis

Citation

Cui Zhixin, Xie Ruijie, ... Schöttker Ben. Associations of selenium status with all-cause and cause-specific mortality: a systematic review and meta-analysis of cohort studies. Redox Biol. 2025-Sep;85:103755. doi:10.1016/j.redox.2025.103755

Abstract

OBJECTIVE: To provide a systematic review and meta-analysis of population-based cohort studies on the association of selenium status with all-cause and cause-specific mortality. METHODS: Relevant studies were identified through systematic searches of MEDLINE and ISI Web of Knowledge. Risk ratios (RRs) reported across categories of selenium biomarkers were recalculated as continuous RR estimations per standard deviation (SD) using generalized least squares for linear trend estimation and pooled in random effects meta-analyses. RESULTS: The literature search identified 20 studies, including 17 studies on all-cause mortality, 9 studies on cardiovascular mortality and 7 on cancer mortality. An increase of selenium biomarker concentration by one SD was associated with 13 % lower all-cause mortality (RR [95 %-confidence interval], 0.87 [0.83-0.90]), 11 % lower cardiovascular mortality (0.89 [0.84-0.94]) and 15 % lower cancer mortality (0.85 [0.78-0.94]). Although moderate heterogeneity was observed, the inverse association with all-cause mortality was robust across countries with low or adequate selenium supply, selenium measurement methods, recruitment years, study quality scores, follow-up lengths and sample sizes. The trim and fill method showed no indications of relevant publication bias. CONCLUSION: Selenium biomarkers are inversely associated with all-cause, cardiovascular and cancer mortality in the general population and clinical trials among selenium deficient populations are still needed.

Key Findings

The literature search identified 20 studies, including 17 studies on all-cause mortality, 9 studies on cardiovascular mortality and 7 on cancer mortality. An increase of selenium biomarker concentration by one SD was associated with 13 % lower all-cause mortality (RR [95 %-confidence interval], 0.87 [0.83-0.90]), 11 % lower cardiovascular mortality (0.89 [0.84-0.94]) and 15 % lower cancer mortality (0.85 [0.78-0.94]). Although moderate heterogeneity was observed, the inverse association with all

Outcomes Measured

  • Requires manual extraction

Population

Field Value
Population See abstract
Sample Size 20
Age Range See abstract
Condition See abstract

MeSH Terms

  • Humans
  • Selenium
  • Cardiovascular Diseases
  • Neoplasms
  • Biomarkers
  • Cohort Studies
  • Cause of Death

Evidence Classification

  • Level: Meta Analysis
  • Publication Types: Journal Article, Systematic Review, Meta-Analysis, Research Support, Non-U.S. Gov't
  • Vertical: selenium

Provenance

Source extracted via PubMed E-utilities API on 2026-04-09